Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. Cancer J Clin. 2024;74(1):12–49.

Article  Google Scholar 

Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, Jemal A, Siegel RL. Breast Cancer Statistics, 2022. Cancer J Clin. 2022;72(6):524–41.

Article  Google Scholar 

Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15–23.

Article  PubMed  PubMed Central  Google Scholar 

Smolarz B, Nowak AZ, Romanowicz H. Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). Cancers. 2022;14(10):89.

Article  Google Scholar 

Li T, Mello-Thoms C, Brennan PC. Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence. Breast Cancer Res Treat. 2016;159(3):395–406.

Article  CAS  PubMed  Google Scholar 

Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer-Targets Ther. 2019;11:151–64.

Article  Google Scholar 

Burguin A, Diorio C, Durocher F. Breast Cancer Treatments: Updates and New Challenges. J Person Med. 2021;11(8):808.

Article  Google Scholar 

Stabellini N, Cullen J, Cao L, Shanahan J, Hamerschlak N, Waite K, Barnholtz-Sloan JS, Montero AJ. Racial disparities in breast cancer treatment patterns and treatment related adverse events. Sci Rep. 2023;13(1):4578.

Article  Google Scholar 

Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2021;124(1):13–26.

Article  PubMed  Google Scholar 

Banerjee K, Resat H. Constitutive activation of STAT3 in breast cancer cells: A review. Int J Cancer. 2016;138(11):2570–8.

Article  CAS  PubMed  Google Scholar 

Johnson DE, O’Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levy DE. What does Stat3 do?. J Clin Investig. 2002;109(9):1143–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan Y, Mao R, Yang J. NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell. 2013;4(3):176–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manore SG, Doheny DL, Wong GL, Lo H-W. IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment. Front Oncol. 2022;12:90.

Article  Google Scholar 

Zhao C, Li H, Lin H-J, Yang S, Lin J, Liang G. Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism. Trends Pharmacol Sci. 2016;37(1):47–61.

Article  PubMed  Google Scholar 

Siveen KS, Sikka S, Surana R, Dai X, Zhang J, Kumar AP, Tan BKH, Sethi G, Bishayee A. Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors. Biochimica Et Biophysica Acta-Reviews on Cancer. 2014;1845(2):136–54.

Article  CAS  Google Scholar 

Muthu K, Panneerselvam M, Topno NS, Jayaraman M, Ramadas K. Structural perspective of ARHI mediated inhibition of STAT3 signaling: An insight into the inactive to active transition of ARHI and its interaction with STAT3 and importinβ. Cell Signal. 2015;27(4):739–55.

Article  CAS  PubMed  Google Scholar 

Sgrignani J, Garofalo M, Matkovic M, Merulla J, Catapano CV, Cavalli A. Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development. Int J Mol Sci. 2018;19(6):89.

Article  Google Scholar 

Yu H, Lee H, Herrmann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014;14(11):736–46.

Article  CAS  PubMed  Google Scholar 

Kim K, Kim S-J, Han YT, Hong S-J, An H, Chang D-J, Kim T, Lim B, Lee J, Surh Y-J, et al. Identification of small molecule inhibitors of the STAT3 signaling pathway: Insights into their structural features and mode of action. Bioorg Med Chem Lett. 2015;25(22):5444–8.

Article  CAS  PubMed  Google Scholar 

Li Y-J, Zhang C, Martincuks A, Herrmann A, Yu H. STAT proteins in cancer: orchestration of metabolism. Nat Rev Cancer. 2023;23(3):115–34.

Article  PubMed  Google Scholar 

Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE Jr. Stat3 as an oncogene. Cell. 1999;98(3):295–303.

Article  CAS  PubMed  Google Scholar 

Ushijima R, Sakaguchi N, Kano A, Maruyama A, Miyamoto Y, Sekimoto T, Yoneda Y, Ogino K, Tachibana T. Extracellular signal-dependent nuclear import of STAT3 is mediated by various importin alphas. Biochem Biophys Res Commun. 2005;330(3):880–6.

Article  CAS  PubMed  Google Scholar 

Wang Y, Shen Y, Wang S, Shen Q, Zhou X. The role of STAT3 in leading the crosstalk between human cancers and the immune system. Cancer Lett. 2018;415:117–28.

Article  CAS  PubMed  Google Scholar 

Tolomeo M, Cascio A. The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy. Int J Mol Sci. 2021;22(2):67.

Article  Google Scholar 

Loh C-Y, Arya A, Naema AF, Wong WF, Sethi G, Looi CY. Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication. Front Oncol. 2019;9:8.

Article  Google Scholar 

Lee H, Jeong AJ, Ye S-K. Highlighted STAT3 as a potential drug target for cancer therapy. BMB Rep. 2019;52(7):415–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Furtek SL, Backos DS, Matheson CJ, Reigan P. Strategies and Approaches of Targeting STAT3 for Cancer Treatment. ACS Chem Biol. 2016;11(2):308–18.

Article  CAS  PubMed  Google Scholar 

Carpenter RL, Lo H-W. STAT3 Target Genes Relevant to Human Cancers. Cancers. 2014;6(2):897–925.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chai EZP, Shanmugam MK, Arfuso F, Dharmarajan A, Wang C, Kumar AP, Samy RP, Lim LHK, Wang L, Goh BC, et al. Targeting transcription factor STAT3 for cancer prevention and therapy. Pharmacol Ther. 2016;162:86–97.

Article  CAS  PubMed  Google Scholar 

Huynh J, Chand A, Gough D, Ernst M. Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map. Nat Rev Cancer. 2019;19(2):82–96.

Article  CAS  PubMed  Google Scholar 

Kohal R, Bisht P, Das Gupta G, Verma SK. Targeting JAK2/STAT3 for the treatment of cancer: A review on recent advancements in molecular development using structural analysis and SAR investigations. Bioorganic Chem. 2024;143:8.

Article  Google Scholar 

Mohan CD, Rangappa S, Preetham HD, Nayaka SC, Gupta VK, Basappa S, Sethi G, Rangappa KS. Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature. Semin Cancer Biol. 2022;80:157–82.

Article  CAS  PubMed  Google Scholar 

Wang T, Fahrmann JF, Lee H, Li Y-J, Tripathi SC, Yue C, Zhang C, Lifshitz V, Song J, Yuan Y, et al. JAK/STAT3-Regulated Fatty Acid β-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance. Cell Metab. 2018;27(1):136.

Article  CAS  PubMed